Inhaler
11980711 ยท 2024-05-14
Assignee
Inventors
- Donald SMITH (Edinburgh, GB)
- Gregor John McLennan ANDERSON (London, GB)
- Lisa Charleston MCMYN (West Linton, GB)
- Alan Miller SUTTIE (Glasgow, GB)
Cpc classification
A61M15/0028
HUMAN NECESSITIES
A61M15/0061
HUMAN NECESSITIES
A61M15/0043
HUMAN NECESSITIES
International classification
Abstract
A device for inhaling an active agent is provided that can be moved from a first configuration to a second configuration. The device comprises two flexible substrates and a membrane located between the two flexible substrates, and the two flexible substrates being connected at two opposing edges and unconnected at two further opposing edges. An active agent provided on the membrane may be inhaled by a user when the device is in the second configuration.
Claims
1. An inhaler, comprising: two flexible substrates connected at first two opposing edges that extend along a length of the two flexible substrates and unconnected at second two opposing edges that meet the first two opposing edges such that the two flexible substrates are movable between a first configuration where the two flexible substrates are substantially flat and in contact with one another and a second configuration where the two flexible substrates are flexed such that a channel forms between the two flexible substrates, extends along the length thereof, and opens at the second two opposing edges; and a membrane mounted between the two flexible substrates in the channel within an opening positioned in a reduced portion of the channel, the reduced portion having the smallest cross-section of the channel and configured to restrict air flow through the channel to increase a rate of air flow through the membrane and a force exerted by the air flow on an active agent on the membrane to lift the active agent from the membrane and into the air flow when the inhaler is in the second configuration such that the active agent disposed on the membrane may be inhaled by a user when the inhaler is in the second configuration.
2. The inhaler according to claim 1, wherein the two flexible substrates are one of rectangular, square, or oblong.
3. The inhaler according to claim 1, wherein the two flexible substrates are biodegradable.
4. The inhaler according to claim 1, wherein the two flexible substrates are card sheets, card sheets coated with a plastic, or plastic.
5. The inhaler according to claim 1, wherein at least a portion of one or both of the two flexible substrates comprises a metallic coating.
6. The inhaler according to claim 1, wherein a cross-section of the channel is reduced in the channel at at least one of the second two opposing edges.
7. The inhaler according to claim 1, further comprising a seal on at least one side of the membrane.
8. The inhaler according to claim 7, wherein the seal is adjacent to a first opening and a second opening of the channel.
9. The inhaler according to claim 1, wherein at least one of the two flexible substrates comprise a reinforcing element.
10. The inhaler according to claim 9, wherein the reinforcing element is adjacent to at least one of a first opening or a second opening of the channel.
11. The inhaler according to claim 9, wherein the reinforcing element is a strip of material that is stiffer than the two flexible substrates.
12. The inhaler according to claim 1, wherein the membrane is a mesh.
13. The inhaler according to claim 1, wherein the membrane is air permeable.
14. The inhaler according to claim 1, wherein the membrane is mounted to both of the two flexible substrates.
15. The inhaler according to claim 1, wherein the membrane is flexible and is one of folded or collapsed when the inhaler is in the first configuration.
16. The inhaler according to claim 1, wherein the active agent is present on the membrane.
17. The inhaler according to claim 16, wherein the active agent is in particulate form.
18. The inhaler according to claim 16, wherein the active agent is an inhalable active agent selected from the group consisting of tramadol, gabapentin, Vicodin (registered trade mark), ibuprofen, acetaminophen, hydrocodone, naproxen, methadone, codeine, hydroxyzine, paracetamol, aspirin, insulin, canagliflozin, alogliptin benzoate, dapaglifozin, empagliflozin, ranibizumab, duglaglutide, pioglitazone hydrochloride, glimepiride, oxytocin, and sildenafil.
Description
BRIEF DESCRIPTION OF THE FIGURES
(1) Embodiments of the present invention will now be described, by way of non-limiting example, with reference to the accompanying drawings.
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
DETAILED DESCRIPTION
(20) While the making and using of various embodiments of the present invention are discussed in detail below, it should be appreciated that the present invention provides many applicable inventive concepts that can be embodied in a wide variety of specific contexts. The specific embodiments discussed herein are merely illustrative of specific ways to make and use the invention and do not delimit the scope of the invention.
(21) To facilitate the understanding of this invention, a number of terms are defined below. Terms defined herein have meanings as commonly understood by a person of ordinary skill in the areas relevant to the present invention. Terms such as a, an and the are not intended to refer to only a singular entity, but include the general class of which a specific example may be used for illustration. The terminology herein is used to describe specific embodiments of the invention, but their usage does not delimit the invention, except as outlined in the claims.
(22) With reference to
(23) The inhaler is configured to move between two configurations, a closed configuration as shown in
(24) The inhaler is retained before use in a sealed water proof envelope to ensure that the salbutamol on the mesh does not come into contact with water.
(25) When the inhaler is to be used, the inhaler is removed from the water proof envelope. The user pinches the two sides of the inhaler that are connected together to move the inhaler from the closed configuration to the open configuration (see
(26) In an alternative embodiment, with reference to
(27) With reference to
(28) When the device is moved from the first configuration to the second configuration, the seals 110, 112 are broken and the membrane 106 is exposed for use.
(29) In a further alternative embodiment, with reference to
(30) Accordingly, the reinforcing strips assist the user to open the device by moving the device from the closed configuration to the open configuration.
(31) In a yet further embodiment, the two card sheets comprise creases (not shown) acting as flexible regions that bias the device towards the open configuration. Accordingly, the device may more readily open when pressure is applied to the connected opposing edges by the user.
(32) In another embodiment, the mesh comprises particles that comprise an inhalable form of insulin as the active agent.
(33) With reference to
(34) In a first configuration (shown in
(35) With reference to
(36) A variation of the device shown in
(37) A similar effect may be achieved by devices with channels that narrow to an aperture such as those shown in
(38) A membrane 402 mounted in a support 404 is shown in
(39) It will be appreciated by the person skilled in the art that the above embodiments are examples and that the features of each disclosed embodiment may be combined with the features of other embodiments. Further variations and modifications are herein contemplated and included in the present invention.